Reddit Posts
Anybody holding INM? What is happening without any news?
Feetr Data Dump: FRC PACW WAL NYCB HUBC INM LYLT
MSGM and INM primed for movement. Both are prior runners. INM is seeing more volume. MSGM is gaining attention online. Worth watching.
$INM same investors as $BBAI, high CTB and Short Interest. 5$ cash per share
$INM top 10 squeeze plays. Low volume aswell could rocket with volume/PR
$INM $MDGS $ELVT $ARDX--Ideas for Traders
$INM $MDGS $ELVT $ARDX--Ideas for Traders
INM Price Target 2022 | InMed Pharmaceuticals Analyst Ratings $150
INM Price Target 2022 | InMed Pharmaceuticals Analyst Ratings $150
$INM real party hasn't started yet. Tomorrow RS with 600k float, we moon
Don't sleep on $INM, the reverse split low float play on Wednesday
$INM, tiny float play after reverse split on Sep 7th, it's hot now.
(NASDAQ-CM: $INM) InMed Pharmaceuticals - Recap Summary
InMed Pharmaceuticals (NASDAQ-CM: $INM) Leader In Pharma
InMed Pharmaceuticals Recent Highlights (NASDAQ-CM: $INM)
InMed Pharmaceuticals Recent Highlights (NASDAQ-CM: $INM)
A biotech stock that I am actually excited to see next earnings report on. Inmed ( NASDAQ: $INM ) $1/share book value and more cash on hand than current market cap. Currently at .75/share - analysis , TLDR
A biotech stock that I am actually excited to see next earnings report on. Inmed (NASDAQ: INM) $1/share book value and more cash on hand than current market cap. Currently at .75/share - analysis
A biotech stock that I am actually excited to see next earnings report on. Inmed (NASDAQ: INM) $1/share book value and more cash on hand than current market cap. Currently at .75/share
Inmed Pharma (INM) - Cannabinoid Manufacturing for the Health and Beauty B2B
Hear me out PLEASE!!! Regarding ticker symbol INM (INMED PHARMACEUTICALS)
INM -EZ DD, Short Read, Want to share my thoughts
Manipulation at its finest. $INM. This is ridiculous. We need help. MM trying to keep it down.
#afterhours #watchlist 08/31 $UNAM - no news, $PLAN - earnings released, $IHT - no news, $INM - no news
A little clarification: I bought a call option that expires on 6/25 for xxx. If the stock surpasses that early and I exercise, do I need to have the funds in my account, or are the costs taken from the gains from that contract?
Mentions
INM Inmed Pharmaceuticals up over 9% and climbing
My 115 ANF leaps were down 90% and could be INM 3 months later. What a rollercoaster
From time to time I keep up with the following. - Inmed Pharma - INM: but they keep reverse splitting and diluting. I hope the Alzheimer research goes somewhere. They'll continuously need more money and wont find partnerships yet since Big Pharma will continue to wait out legislative developments. - Medipharm Labs - LABS : was a long time favorite of mine. Very connected, delivered for opioid trials, ex CEO of Purdue Pharma Canada as CEO. But they are now dealing with a hostile takeover attempt and they will need to spend time and resources on that, which is a hige distraction and insecurity. - Incannex healthcare- IXHL: was interesting for Sleep apnea - until hype pumpers took over and now it is simply a pump and dump stock that will go through some cycles of swing trades until all the pumpers, that barely know the company name, leave. There is also a lot of competition for sleep apnea lately. So it might be case closed here. - Lexaria biosciences - LEXX: they will probably reverse split sooner or later to remain on nasdaq. They still have a "big" partnership to reveal so this might help. But Kennedy isn't favorable on GLP drugs anymore. So the government is gonna work against this. - Sandoz for the biosimilars. Where syntethic cannabinoids come in. But again, to be seen ifbthe government supports this. Biden pushed for lower drug prices by supporting generics. I don't see the current administration moving on that direction. - Charlotte's Web- CWBHF: lots of ties to pharma and tobacco companies. You'd think this stock price would be a lot higher. But ot never seems to get any love. And time and governmental delays work against the potential of success. - Aurora cannabis- ACB: they've chosen a stronger focus on medical grade cannabis - internationally - , compared to other "mainstream" weedstocks. But of course, it all depends on politics. - Tilray - TLRY: they are advancing studies. But they are obviously spread to thin. What was an advantage in the beginning, to bet on the broad spectrum of cannabis potential (alcohol, medical, recreational, CPG) is now biting them in the *ss. Since, again, ot all hinges on legislation and it is now only taking up resources. They'll need to consolidate themselves so we will see what remains of those expensive studies.. Generally soeaking the pharmaceuticalization of the tobacco sector is interesting to keep track off. And the Abott laboratories type of companies for GMO seeds. But, as stated, it all depends on politics at the moment. And delays, time, is the enemy of financial resources. So it is not favorable at the moment. I would not be surprised to see several of these companies go belly up in the next couple of years.
$TNFA – Set up like past low-float biotech runners 📈 ✅ Float: ~13M – ultra tight like $SBFM, $INM, $IXHL before their runs ✅ Institutional confidence: Morgan Stanley increased position 61% in Q1 2025 (holds 3.7%) ✅ Imminent Phase 2b data – Isomyosamine trial started Feb, 150+ days passed ✅ Warrant wall at $0.364 – could be incentive to push above and raise capital ✅ Oversold bounce + reclaim of 50DMA + falling wedge breakout ✅ High short interest + retail starting to notice 🧠 Similar past plays: • $SBFM – Ran from $0.22 to $1.60 on cancer data • $INM – <$0.20 to $0.95 after clean Phase 2 and short squeeze • $IXHL – Quiet under $0.30, exploded past $1+ on trial news 🎯 TNFA Price Targets: • Base case: $0.50–$0.80 • Squeeze/FOMO: $1+ like $IXHL This is one to keep eyes on. Microcap biotech, huge upside, real catalyst window NOW.
1Aug, 8Aug, Dec, May26 and Jul26 $15, $16 and $17 calls. I learnt the hard way to buy only INM calls. I do believe that the stock is fairly undervalued with the 10% drop today!
INM, youre really huting me now
INM teased me really good for a sec just to tell me she wasnt in the mood afterall
Cheer up, INM You're not this bad
anyone in INM? I woke up late..but I'm wondering if it could dump a little at open and then pop back up
how about buying INM(Inmed)?
Anti-ageing and increased mental capacity through cannabis A low-dose long-term administration of cannabis can not only reverse aging processes in the brain, but also has an anti-aging effect. The results are now presented in the journal "ACS Pharmacology & Translation Science". https://www.uni-bonn.de/en/news/164-2024 Or https://www.northernvirginiahemp.com/s/stories/discover-how-thc-might-be-the-key-to-reversing-brain-aging Good thing we will have more time to finally make some money out of this sector. And this definitely supports Inmed Pharma (INM) their focus on mitigating/ healing age related diseases with cannabinoids. (Alzheimers and Eye health)
Thoughts on TGL, INM, or HOLO Tomorrow?
Thoughts on INM, HOLO, or TGL for tomorrow?
Nobody talking about INM?
Vol has increased on INM late. Any idea why? They are under the NASDAQ gun because they've been warned they must get sp over $1.00. sp wavering between $0.23 to $0.25
INM close $0.2276, -$0.0185, -7.29% vol. 621.03K...avg daily vol 629.97K (NASDAQ) share outstanding 8.36M...public float n/a
INM has been slow gapping up, I think it has the potential to squeeze any day. Low float
With all due respect, it’s dead and you shouldn’t have emotionally traded and taken profits when it doubled for you. People are hopping on GWAV now it looks like to ride that to a $1. INM is my back pocket play as well
Or we could do the same thing on something like INM, which has 1/10 the market cap and much less volume.
INM squeezing upwards, $1 soon
I hate to hear it for you. I’ve done that same thing a few too many times. I would say the same as many in this post about ETF’s being a safer spot for money, especially as a student. But having $15000 to just put in a penny stock as a student? Wow. For what it’s worth, I am liking the potential for $INM, another penny stock. Could reap some of your losses there with me, but of course this is by no means financial advice.
INM has the lowest float and can rise quickly. Needs to get back to a $1 for NASDAQ compliance and meets all other requirements. Idk why people aren’t interested when only a quarter of the volume from BNED or FFIE is needed to move it They’re developing a cannabis cure for Alzheimer’s among other projects.
I told you guys to look at INM, it was a safe play with a lot of upside
Yep, HOLO, INM and BDRX for me.
INM, take a look, low volume, needs less than half the volume of BNED and FFIE to move and needs to get back to a $1/share
INM has been on an upward trend, just needs the volume to run. Barron has it valued at 20/share
I’m in BDRX, HOLO, and INM.
I'm in HOLO 1.90 avg do you think INM has potential?
HOLO and INM also haven’t popped yet and are already being talked about.
Shorted FFIE, bought INM, HOLO, and BRDX. Up $10k on FFIE and BRDX so far.
INM and HOLO both are getting some interest and volume but haven’t taken off yet.
The pennystock sub is hyping $HOLO, so I picked up some of that, along with $INM and $BDRX.
You can always have both even if one is a small position. INM’s is slowly picking up and it’s being picked up by some bigger investors on Stocktwits I think it can potentially ride to $1 since that’s the only thing it needs to meet NASDAQ compliance, everything else is covered
Short interest for BRDX is 97.6%! INM's 6.41% short interest is a bit too low
Congrats on the gains, and enjoy the Porsche! You guys should take a look at INM as well if you’re interested. Super low float and has been casually trending upward
I think it’s just a capital used to fund their project type of thing they announced back in October of last year which shot the stock price upto a $1, “advancing INM-901, a cannabinoid analog, in its pharmaceutical drug development program”. It looks like this would treat Alzheimer’s But then this happen which made the stock price go down, “InMed Pharmaceuticals (NASDAQ:INM) plans to raise $5.2 million through a private placement offering, the company said Tuesday. The company has entered into definitive agreements for the issuance and sale of 3,012,049 of its common shares or pre-funded warrants in lieu thereof and preferred investment options to purchase up to 3,012,049 common shares. The purchase price would be $0.83 per share, or a pre-funded warrant in lieu thereof, and an associated preferred investment option In the end, it supposed to be valued around $2/share at least and has positive value in terms of actual returns. With the NASDAQ compliance issue, I think it’s planning on popping back to a $1 at least since they meet all other requirements
$INM looks to be a solid move, they’re meeting all other reqs other than the $1/share listing on the NASDAQ and had a positive earnings report “InMed Pharmaceuticals Inc., a global leader in cannabinoid-based therapeutics, has been granted a 180-day extension by Nasdaq to meet the minimum bid price requirement for continued listing, which now gives the company until September 16, 2024, to achieve compliance. The company has already met all other listing requirements, and the stock will continue to trade under the symbol ‘INM’ The shares can move in an absolute hurry, extremely low float. If this wasn’t a move, I wouldn’t be talking about it
InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a clinical stage pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates, today announced financial results and business update for the third quarter of the fiscal year 2024, which ended March 31, 2024.
InMed (NASDAQ: INM) Developing Cannabinoids Analogs To Treat Alzheimer's – New Studies Showcase INM-901's Therapeutic Abilities "There are several treatments on the market, but they focus on addressing the symptoms rather than repairing and regenerating the damaged neurons. Some drugs and treatments may slow the progression of cognitive decline, but none can reverse the effects of Alzheimer's. That may change thanks to companies like InMed Pharmaceuticals Inc. The leader in cannabinoid and cannabinoid analogs pharmaceutical research, development, manufacturing and commercialization has identified a rare cannabinoid to treat Alzheimer's. " https://www.benzinga.com/partner/biotech/24/05/38639416/inmed-nasdaq-inm-developing-cannabinoids-analogs-to-treat-alzheimers-new-studies-showcase-inm-901
$INM $ZLDAF thedalesreport.com/ inmedpharma.com/ zeliratx.com/ zeliratx.com/research/clini...
Cannabis and Cognition Making use of an ancient plant's benefits today. There are now nearly 6 million people in the U.S. with Alzheimer’s disease (AD) and related dementias, and that number is projected to increase substantially in the coming decades. Though there is still much mystery as to why AD occurs, what is quite clear is that specific regions of the brain are affected. ... There’s increasing evidence to suggest cannabis can help. Seniors, who make up the majority of the population with dementia, are increasingly embracing cannabis, often for relief from the aches, pains, and insomnia that come with age. According to a 2022 federal survey, 8% of people 65 and older re ... What I’ve learned is that cannabis can have a neuroprotective effect on the brain, seeming to ameliorate or mitigate degenerative, traumatic, and inflammatory processes that can occur with aging (3) as well as affect neuroplasticity (i.e., allowing new neural pathways to develop to replace those that are no longer functioning). https://www.psychologytoday.com/us/blog/bedside-manners/202404/cannabis-and-cognition Combine that with Inmed's news yesterday, and you can call me a happy camper: InMed's INM-901 Demonstrates Favorable Pharmacological and Behavioral Effects in In Vivo Preclinical Alzheimer's Disease Studies https://finance.yahoo.com/news/inmeds-inm-901-demonstrates-favorable-120000340.html
My cava calls were up 40% earlier but now in the red like -18%, luckily my CELH calls are soaring to pick up the slack, too bad I sold half of them Friday that were way INM then that I was gonna use the money for to buy new OTM calls this week for earnings but it soared today so I didn't buy the new calls
Busy day. Added **massively** to CWBHF. Also added to MRMD, GRWG, INM, CYBN. Bought calls: ACB, GRWG, MSOS, CGC, TLRY
I think I'll go ahead and sell my INM TQQQ calls expiring today, I'll let the OTM ones ride a little longer lol
Here are some pennystocks I found that have stuck with the same range for the past couple of weeks. Easy money when you know when you know the ranges. $INM: 0.36 to 0.41 $IKNA: 1.8 to 2.1 $VSME: 0.37 to 0.42 $TCBP: 2.2 to 2.4 Buy when it hits the low value, and sell once it reaches the high value, rinse and repeat and you are golden
INM being weird in early premarket.
I added across the board during the drawdown this week: INM, FFNTF, TLLTF, SHWZ, OGI, DBCCF, CXXIF, JUSHF. Have a nice weekend weedstocks. Keep your eye on the prize. Short term boost is coming, long term thesis will be confirmed. You don't need faith, just patience.
MRMD, TLLTF, CWBHF, GDNSF, STHZF, INM beg to differ and that's just from my holdings. ACB, TSNDF, and TLRY flat and about to turn red too. Risk-On has been coming down a little these last 20-30 minutes.
$IKNA complete overreaction to news, dropped a lot, and is slowly recovering nicely. Also holding $INM And of course, still holding $VSME
Unusual bull volume on INM today. Volatility too. No news or filings that I've seen.
**Love** HITI, warmed up to OGI and building a position, small stakes in CRON, VFF, INM, and SNDL already but can't say I'm convinced of any of them yet. Started CXXIF this week because I like what I've read/heard so far.
Boomer ass INM is gunna save this market 
LIAN and INM up more than 100% 
I am a bot. You submitted a picture of a banned ticker, INM. The market cap of INM is **4,626,190** This check will fire if you included unnecessary pictures that have bad keywords/phrases. Repost with the useless pictures omitted if you did that.
Just taken a position in INM . Looks good to rally over 2$ in next couple of days
Yall should look at INM for tmrw.
I think I’m gonna start loading up on INM shares at open. You guys should check it out.
Check out INM. Looks very cyclical. Should run back up to 1.30 by tomorrow
Two nice charts. Thanks for posting. Would love an entry around $9 on MSGM. INM looks ready to rock. Could see this getting to turn macro .382 for 10x from here!
MSGM is a low float play set to volume run and gaining eyes. 1D and 1H charts look good for another run. INM is another previous runner that triggered a buy signal on my charts. Volume is increasing. Worth a watch. Still holding some TRKA, but stuff is getting too weird for me. I’m gonna ignore it for a few days and maybe people will be chill by then. Got my lunch ate misplaying the EDBL run today, so I guess I’m holding. Watching so other tickets to see if they find support, but none are worth mentioning tonight.
$EDBL $BIOR $TYDE $INM in that order haha
Love it I bought a good amount of $INM this morning
Yea I like $INM! What makes you think it’s solid?
Thought about that one but below $BIOR $EDBL and $INM for me
Nah switching to $EDBL, $TYDE, $BIOR, $INM
So sad I sold last week I thought it would fly but gave up, switching to $EDBL, $BIOR, and $INM
Once it's done, thoughts on $EDBL or $INM or $BIOR next?
I bought a bunch of $EDBL, like their mission of sustainable farming (seems on trend) and they just announced a partnership with the EPA/USDA today.([https://finance.yahoo.com/news/edible-garden-announces-research-partnership-133000871.html](https://finance.yahoo.com/news/edible-garden-announces-research-partnership-133000871.html)) Dropped a ton because they did a stock offering but that just ended this week, and I think a short squeeze could be a possibility - not great reasons, but I could see people rallying behind sustainable farming (who wants a farming business to get destroyed by shorts) and also a fun name with Edible haha. ​ Also like $BIOR (Fintel #3 best short squeeze stock and positive drug trials), $INM (similar to $BIOR, heavily shorted), and $TYDE (Crazy revenue announcement today)
$EDBL - most shorted stock as of update 30 min ago $BIOR - top 3 stock to have a squeeze per Fintel, and had very promising drug trial results $INM - another shorter stock with promising drug trials, pharma stocks are due for a rebound
Bigger on $INM $EDBL $CMPS $BIOR $TYDE
Bigger on $INM $EDBL $CMPS $BIOR $TYDE
Bigger on $INM $EDBL $CMPS $BIOR $TYDE
Bigger on $INM $EDBL $CMPS $BIOR $TYDE
Bigger on $INM $EDBL $CMPS $BIOR $TYDE
Bigger on $INM $EDBL $CMPS $BIOR $TYDE
Bigger on $INM $EDBL $CMPS $BIOR $TYDE
Bigger on $INM $EDBL $CMPS $BIOR $TYDE
Bigger on $INM $EDBL $CMPS $BIOR $TYDE
Prefer $EDBL $BIOR $INM
Believe more in $BIOR $EDBL $INM and $TYDE
Hey /u/kyleperk97 - I am a bot from /r/wallstreetbets. You submitted one or more banned tickers: INM DGLY. We don't allow discussion of low market cap (less than 500mm) tickers to prevent pump & dump spam and scammers.
Anyone else see $INM and $DGLY as the most shorted stocks today? It showed that when I opened it up and then went back to how it was yesterday, but I know 2/9 is when they report updated short interest
MLGO is the best on on the list i believe INM to be far less superior(To much manipulation) IBRX is somewhere in the middle, better than INM but not better than MLGO :) nice to see a person branching out Not financial advise or prediction just opinion
INM - InMed Pharmaceuticals Inc. Super low floater, 28% short float, pulling back to consistent support levels at 1.81 & 1.70 range. Enter wherever it shows consolidation around these levels. Rockets with volume; major resistance levels at 2.31 & 2.57. MLGO - MicroAlgo, Inc. Another very low floater, 36% short float, BIG range. Locked onto 2.11 support and will likely stay there until a catalyst. With Volume, it will rip quickly before pulling back, so take profits and don’t linger. IBRX - ImmunityBio, Inc. Healthier, larger company than the other two. 84M float, 28% short float, consistent volume. Due for a reversal soon, which should hit if the 3.77 support holds on the pullback. If so, enter at support. Big gap to fill back to 6-7 range.